1. Home
  2. CRNX vs WPP Comparison

CRNX vs WPP Comparison

Compare CRNX & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.65

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo WPP plc

WPP

WPP plc

HOLD

Current Price

$15.35

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
WPP
Founded
2008
1985
Country
United States
United Kingdom
Employees
N/A
104000
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CRNX
WPP
Price
$33.65
$15.35
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$74.78
N/A
AVG Volume (30 Days)
1.0M
665.2K
Earning Date
05-07-2026
02-26-2026
Dividend Yield
N/A
13.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,039,000.00
N/A
Revenue This Year
$722.66
N/A
Revenue Next Year
$183.79
$2.48
P/E Ratio
N/A
$38.96
Revenue Growth
N/A
N/A
52 Week Low
$24.10
$14.81
52 Week High
$57.99
$40.95

Technical Indicators

Market Signals
Indicator
CRNX
WPP
Relative Strength Index (RSI) 29.20 34.70
Support Level $33.23 $14.81
Resistance Level $37.23 $19.55
Average True Range (ATR) 1.62 0.51
MACD 0.13 0.05
Stochastic Oscillator 8.33 19.85

Price Performance

Historical Comparison
CRNX
WPP

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About WPP WPP plc

Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.

Share on Social Networks: